Indaptus Therapeutics Inc (INDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,076 | 13,799 | 10,892 | 9,292 | 14,966 |
| Marketable Securities | N/A | N/A | N/A | 770 | 767 |
| Receivables | 609 | 1,307 | 2,638 | 3,683 | 2,453 |
| TOTAL | $17,685 | $15,106 | $13,530 | $13,745 | $18,186 |
| Non-Current Assets | |||||
| PPE Net | 1,680 | 1,967 | 2,272 | 2,575 | 6,200 |
| Other Non-Current Assets | 4,671 | 4,710 | 4,834 | 4,960 | 6,395 |
| TOTAL | $6,351 | $6,677 | $7,106 | $7,535 | $12,595 |
| Total Assets | $24,036 | $21,783 | $20,636 | $21,280 | $30,781 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,550 | 4,379 | 5,117 | 8,342 | 11,608 |
| TOTAL | $4,550 | $4,379 | $5,117 | $8,342 | $11,608 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,409 | 1,226 | 1,299 | 1,403 | 1,686 |
| TOTAL | $1,409 | $1,226 | $1,299 | $1,403 | $1,686 |
| Total Liabilities | $5,959 | $5,605 | $6,416 | $9,745 | $13,294 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35 | 32 | 31 | 24 | 16 |
| Common Shares | 727 | 727 | 727 | 727 | 727 |
| Retained earnings | -199,980 | -196,240 | -193,293 | -189,423 | -182,867 |
| TOTAL | $18,077 | $16,178 | $14,220 | $11,535 | $17,487 |
| Total Liabilities And Equity | $24,036 | $21,783 | $20,636 | $21,280 | $30,781 |